openPR Logo
Press release

Singapore's New Friend in the Block Redefines Venture Capital

08-13-2025 04:02 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

New Friend in the Block: An Evolution of Venture Capital for the AI Age

New Friend in the Block: An Evolution of Venture Capital for the AI Age

Valven Studio is a Singaporebased venture studio redefining VC. Instead of making many bets, it invests in a few highconviction startups and embeds its partners in the team. A rigorous threestage diligence and scorecard choose founders; then playbooks for product or distribution guide growth. Matthew Chew, Michel Padron and Juan Roldan provide handson product, growth and tech expertise to help founders go from 0.5 to 1.
Singapore - 13 August, 2025 - Valven Studio, a venture studio headquartered in Singapore, announces its arrival as a new alternative to venture capital. Born from the frustrations of the traditional VC model-where more than 75 % of VCbacked startups never return capital and founders are often left without operational support (1) [https://valvenstudio.com/posts/venture-studio-early-stage-startup-support/#:~:text=Why%20Traditional%20VC%20Is%20Failing,Modern%20Startups] - Valven offers a founderfriendly partnership that blends capital with handson execution.

"We're not here to spray and pray; we're here to build," said Matthew Chew, General Partner and Product Visionary. "Our approach embeds experienced operators directly into the startup team to turn data into decisive action and tackle overlooked problems."

Beyond VC: How the Model Works

Valven's model starts with a structured diligence process to evaluate potential partners. The three stages include:

*
Founder & Vision Interview - an assessment of character, resilience and coachability (2) [https://valvenstudio.com/posts/selection-process/screening/#:~:text=The%20first%20stage%20of%20Valven%E2%80%99s,vision%2C%20and%20most%20importantly%2C%20coachability]. Valven looks for founders who combine clear vision with intellectual humility and openness to strategic feedback.

*
Business & GTM Deep Dive - pressuretesting the business model, unit economics and gotomarket strategy. The team assesses revenue streams, pricing, distribution engine and the founder's ability to acquire customers.

*
Product & Tech Deep Dive - a comprehensive review of the product's current state, architecture and scalability. Valven classifies the technical maturity as build, scale or rebuild, evaluating code quality, infrastructure and security.

Findings from the diligence process feed into the Valven Scorecard, which quantifies factors such as founder excellence, business model maturity, distribution readiness and technical foundation (3) [https://valvenstudio.com/posts/onboarding/partnership-foundation/#:~:text=Step%201%3A%20The%20Valven%20Scorecard]. Opportunities with strong scores move forward into one of two operational playbooks:

*
Playbook A - Strong Product, Weak Distribution. For startups with validated products but limited customer acquisition, Valven's Growth Partner leads the development of a scalable distribution engine, from founderled content strategies to paid growth campaigns. The Technical Partner ensures the product infrastructure can support rapid growth.

*
Playbook B - Strong Distribution, Weak Product. For ventures with proven customer acquisition but technical gaps, Valven's Technical Partner acts as interim head of engineering, defines the roadmap, builds the team and upgrades the product, while the Growth Partner optimizes revenue from existing channels.

Unlike typical VCs that make dozens of bets and hope a few hit, Valven invests in fewer ventures and commits deeply. Venture studios worldwide show that studiobacked companies have about 30 % higher success rates than typical VCbacked startups, with average IRRs of 53-60 % versus 21-22 % for traditional funds. Valven's approach aims to replicate these outcomes in Southeast Asia.

HandsOn Partners, Not Just Investors

Valven's general partners bring complementary expertise honed through building and scaling ventures:

*
Matthew Chew - General Partner & Product Visionary. A serial founder and product strategist, Matthew believes entrepreneurship is about building tools that render old ways obsolete. He emphasizes rigorous analysis married with swift action and invites founders to harness technology to build a future that matters.

*
Michel Padron - General Partner & Growth Strategist. Michel has built, scaled and exited ventures across fintech, AI and blockchain, learning from successes and failures. As a fractional founder, he merges engineering precision with business leadership to help startups avoid common growth pitfalls. He helps founders build distribution engines and optimize customer acquisition.

*
Juan Roldan - General Partner & Technical Strategist. Fascinated by how things work since childhood, Juan approaches the CTO role as a business enabler. He ensures technology decisions support the company's vision, builds products that are both technically sound and commercially successful and thrives on bridging the gap between code and customer.

From 0 to 0.5 Is Easy - Valven Takes You from 0.5 to 1

Many accelerators and incubators help founders build a minimum viable product. Valven focuses on the messy 0.5-to-1 phase-where companies have an MVP and initial customers and need to scale quickly (4) [https://valvenstudio.com/about/#:~:text=Screening%20We%20start%20by%20screening,Learn%20more%20%E2%86%92]. By embedding its partners directly into the team, Valven provides technical leadership, gotomarket strategy and funding architecture, giving founders a cobuilder rather than just a cheque. The firm's resource deployment model emphasises deep integration and shared accountability: Valven team members work alongside founder teams, sharing both the risk and the upside.

Structured Yet Flexible Engagement

After a playbook is selected, Valven helps founders secure the capital necessary for execution. Playbook A typically requires US$50K-US$250K for marketing, growth hiring and infrastructure; Playbook B needs US$100K-US$400K to hire engineers and build a robust product (5) [https://valvenstudio.com/posts/onboarding/funding-plan/#:~:text=Capital%20Requirements%20by%20Playbook]. Funding may come from existing company capital, a bridge investment from Valven's partners or an orchestrated angel round. Before fully engaging, a fivestage engagement sequence ensures both sides are ready-covering diligence and vote, funding plan, letter of intent, capital confirmation and definitive agreements. This sequencing protects resources, validates readiness and aligns expectations.

A Catalyst for Singapore's Startup Ecosystem

Singapore has long been a hub for venture capital and innovation, yet many founders remain underserved by traditional investors. Valven Studio aims to bridge the gap between early traction and scalable success, bringing an AIenabled venture studio model that prioritizes diversity, founder empowerment and operational excellence. By investing in fewer, higherconviction bets and providing handson operators, Valven offers investors a more thorough duediligence process and founders a partner who will build alongside them. The team invites ambitious founders and forwardthinking investors to learn more and explore detailed insights in Valven's Diligence Process , Partnership Evaluation and Playbook Execution series.

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: Valven Studio
Contact Person: Michel Padron
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=singapores-new-friend-in-the-block-redefines-venture-capital]
Country: Singapore
Website: https://valvenstudio.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Singapore's New Friend in the Block Redefines Venture Capital here

News-ID: 4144262 • Views:

More Releases from ABNewswire

PixNova AI Launches Revolutionary Video and Photo Face Swap Technology, Redefining Creative Media Standards
PixNova AI Launches Revolutionary Video and Photo Face Swap Technology, Redefini …
New AI Face Swap Engine Delivers Unprecedented Speed, Accuracy, and Creative Freedom PixNova AI [https://pixnova.ai/], a global leader in AI-powered image and video generation, today announced the launch of its next-generation Video Face Swap and Photo Face Swap technology. This breakthrough upgrade significantly enhances face swap accuracy and realism while dramatically improving processing speed, empowering creators, film studios, short-form video influencers, and everyday users with a faster, more natural face-swapping experience. Image:
Coastal Comeback: Why the Great British Seaside Holiday Is Here to Stay
Coastal Comeback: Why the Great British Seaside Holiday Is Here to Stay
The British seaside holiday is evolving rather than disappearing. While overnight stays have declined, day trips and short breaks are growing in popularity. Resorts are adapting with modern attractions and events, ensuring the coast remains a beloved and resilient destination. Once defined by deckchairs, sticks of rock, and donkey rides along the sand, the Great British seaside holiday has long been a national tradition. While its form has changed over the
Neurofibromatosis Type 1 Market Expected to Gain Momentum Through 2034, According to DelveInsight | AstraZeneca, Merck, SpringWorks Therapeutics, Healx, Pasithea Therapeutics, Fosun Pharmaceutical
Neurofibromatosis Type 1 Market Expected to Gain Momentum Through 2034, Accordin …
The Key Neurofibromatosis Type 1 Companies in the market include - AstraZeneca and Merck, SpringWorks Therapeutics, Healx, Pasithea Therapeutics, Fosun Pharmaceutical, NFlection Therapeutics, and others. DelveInsight's "Neurofibromatosis Type 1 Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Neurofibromatosis Type 1, historical and forecasted epidemiology as well as the Neurofibromatosis Type 1 market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and
Phenylketonuria Market to Witness Promising Upswing by 2034, DelveInsight Forecasts | PTC Therapeutics, Homology Medicine, Synlogic, BioMarin Pharma
Phenylketonuria Market to Witness Promising Upswing by 2034, DelveInsight Foreca …
The Key Phenylketonuria Companies in the market include - PTC Therapeutics, Homology Medicine, Synlogic, BioMarin Pharmaceuticals, and others. The Phenylketonuria market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Phenylketonuria pipeline products will significantly revolutionize the Phenylketonuria market dynamics. DelveInsight's "Phenylketonuria Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Phenylketonuria, historical and forecasted epidemiology as

All 5 Releases